|
Lymphoid Neoplasia
Citations 131-140 of 299 total displayed.
|
Past content
(since Jan 2009):
|
Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study
- Ola Landgren, Robert A. Kyle, Jane A. Hoppin, Laura E. Beane Freeman, James R. Cerhan, Jerry A. Katzmann, S. Vincent Rajkumar, and Michael C. Alavanja
Blood 2009; 113: 6386-6391.
[Abstract]
[Full text]
[PDF]
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
- Antonio Di Stasi, Biagio De Angelis, Cliona M. Rooney, Lan Zhang, Aruna Mahendravada, Aaron E. Foster, Helen E. Heslop, Malcolm K. Brenner, Gianpietro Dotti, and Barbara Savoldo
Blood 2009; 113: 6392-6402.
[Abstract]
[Full text]
[PDF]
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
- Kieron Dunleavy, Stefania Pittaluga, Myron S. Czuczman, Sandeep S. Dave, George Wright, Nicole Grant, Margaret Shovlin, Elaine S. Jaffe, John E. Janik, Louis M. Staudt, and Wyndham H. Wilson
Blood 2009; 113: 6069-6076.
[Abstract]
[Full text]
[PDF]
Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
- Kjeld Schmiegelow, Ibrahim Al-Modhwahi, Mette Klarskov Andersen, Mikael Behrendtz, Erik Forestier, Henrik Hasle, Mats Heyman, Jon Kristinsson, Jacob Nersting, Randi Nygaard, Anne Louise Svendsen, Kim Vettenranta, and Richard Weinshilboum, for the Nordic Society for Paediatric Haematology and Oncology
Blood 2009; 113: 6077-6084.
[Abstract]
[Full text]
[PDF]
Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL
- Sang-Woo Kim, Deepak Rai, Morgan R. McKeller, and Ricardo C. T. Aguiar
Blood 2009; 113: 6153-6160.
[Abstract]
[Full text]
[PDF]
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma
- Edmund A. Rossi, David M. Goldenberg, Thomas M. Cardillo, Rhona Stein, and Chien-Hsing Chang
Blood 2009; 113: 6161-6171.
[Abstract]
[Full text]
[PDF]
Targeting the Notch1 and mTOR pathways in a mouse T-ALL model
- Kathleen Cullion, Kyle M. Draheim, Nicole Hermance, Jennifer Tammam, Vishva M. Sharma, Christopher Ware, George Nikov, Veena Krishnamoorthy, Pradip K. Majumder, and Michelle A. Kelliher
Blood 2009; 113: 6172-6181.
[Abstract]
[Full text]
[PDF]
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
- John F. DiPersio, Edward A. Stadtmauer, Auayporn Nademanee, Ivana N. M. Micallef, Patrick J. Stiff, Jonathan L. Kaufman, Richard T. Maziarz, Chitra Hosing, Stefan Früehauf, Mitchell Horwitz, Dennis Cooper, Gary Bridger, Gary Calandra, and for the 3102 Investigators
Blood 2009; 113: 5720-5726.
[Abstract]
[Full text]
[PDF]
Hodgkin lymphoma in the Swiss HIV Cohort Study
- Gary M. Clifford, Martin Rickenbach, Mauro Lise, Luigino Dal Maso, Manuel Battegay, Julia Bohlius, Emmanuelle Boffi El Amari, Urs Karrer, Gernot Jundt, Andrea Bordoni, Silvia Ess, Silvia Franceschi, and for the Swiss HIV Cohort Study
Blood 2009; 113: 5737-5742.
[Abstract]
[Full text]
[PDF]
Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma
- Weiyun Z. Ai, Robert Tibshirani, Behnaz Taidi, Debra Czerwinski, and Ronald Levy
Blood 2009; 113: 5743-5746.
[Abstract]
[Full text]
[PDF]
|
|
